Smith & Nephew (SNN) Other Accumulated Expenses (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Other Accumulated Expenses of $190.0 million for Q4 2025, up 100.0% year-on-year from $95.0 million in Q4 2024, and up 97.92% on a QoQ basis from $96.0 million in Q2 2025.
Smith & Nephew (SNN) Other Accumulated Expenses (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Other Accumulated Expenses for 16 consecutive years, with $190.0 million the latest figure, recorded in Q4 2025.
- Quarterly Other Accumulated Expenses rose 100.0% year-over-year to $190.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $190.0 million (up 100.0% YoY) and the FY2025 annual result came in at $190.0 million, up 100.0% from the prior year.
- Other Accumulated Expenses improved to $190.0 million in Q4 2025 per SNN's latest filing, from $96.0 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for SNN reached as high as $190.0 million in Q4 2025 and fell as low as $35.0 million in Q4 2023.
- A 5-year average of $95.6 million and a median of $95.0 million in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses tumbled 61.11% — and 2024, when it soared 171.43%.
- Year by year, Other Accumulated Expenses stood at $67.0 million in 2021, then soared by 34.33% to $90.0 million in 2022, then slumped by 61.11% to $35.0 million in 2023, then surged by 171.43% to $95.0 million in 2024, then surged by 100.0% to $190.0 million in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $190.0 million, $96.0 million, and $95.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 190.00 Mn |
| Jun 28, 2025 | 96.00 Mn |
| Dec 31, 2024 | 95.00 Mn |
| Jun 29, 2024 | 96.00 Mn |
| Dec 31, 2023 | 35.00 Mn |
| Dec 31, 2022 | 90.00 Mn |
| Dec 31, 2021 | 67.00 Mn |
| Dec 31, 2020 | 94.00 Mn |
| Jun 30, 2020 | 105.00 Mn |
| Dec 31, 2019 | 102.00 Mn |
| Jun 29, 2019 | 116.00 Mn |
| Dec 31, 2018 | 53.00 Mn |
| Jun 30, 2018 | 94.00 Mn |
| Dec 31, 2017 | 128.00 Mn |
| Dec 31, 2016 | 82.00 Mn |
| Dec 31, 2015 | 29.00 Mn |
| Dec 31, 2014 | 44.00 Mn |
| Dec 31, 2013 | 7.00 Mn |
| Mar 31, 2013 | 8.00 Mn |
| Dec 31, 2012 | 8.00 Mn |